Last year, Immunai, a New York and Tel Aviv-based biotech company, launched with the ambitious goal of mapping the Read More
Immunai raises $60M with the goal of reprogramming the human immune system
It hasn’t been all that long since we unlocked the human genome, but the effect on healthcare has Read More